Pliant Therapeutics, Inc. (PLRX)

NASDAQ: PLRX · Real-Time Price · USD

1.150

-0.015 (-1.29%)

At close: May 15, 2026, 4:00 PM EDT

1.140

-0.010 (-0.87%)

After-hours: May 15, 2026, 4:54 PM EDT

Pliant Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	71	75	802	1,085	946	487
Market Cap Growth	-27.40%	-90.65%	-26.14%	14.71%	94.21%	-39.69%
Enterprise Value	-69.67	-88.32	505.46	600.98	628.21	291.85
Last Close Price	1.15	1.22	13.17	18.11	19.33	13.50
PE Ratio	-	-0.50	-3.80	-6.59	-6.57	-4.98
PS Ratio	-	-	-	686.82	97.68	64.33
PB Ratio	0.44	0.41	2.64	2.29	3.02	2.45
P/TBV Ratio	0.43	0.41	2.62	2.25	2.59	2.43
P/FCF Ratio	-	-0.58	-5.03	-9.25	-9.81	-6.29
P/OCF Ratio	-	-0.58	-5.15	-9.33	-10.00	-6.46
EV/Sales Ratio	-	-	-	380.37	64.86	38.54
EV/EBITDA Ratio	-	0.57	-2.23	-3.30	-5.01	-3.04
EV/EBIT Ratio	-	0.56	-2.21	-3.26	-4.94	-2.99
EV/FCF Ratio	-	0.69	-3.17	-5.12	-6.52	-3.77
Debt / Equity Ratio	0.16	0.15	0.20	0.02	0.04	0.03
Debt / EBITDA Ratio	-0.24	-0.19	-0.27	-0.06	-0.13	-0.07
Debt / FCF Ratio	-0.29	-0.23	-0.38	-0.10	-0.16	-0.09
Net Debt / Equity Ratio	-0.86	-0.89	-0.97	-1.02	-1.01	-0.97
Net Debt / EBITDA Ratio	1.21	1.05	1.31	2.65	2.52	2.02
Net Debt / FCF Ratio	1.44	1.26	1.86	4.12	3.27	2.50
Asset Turnover	-	0	0	0.00	0.03	0.03
Quick Ratio	16.50	11.67	10.71	17.33	13.94	12.04
Current Ratio	16.89	12.00	10.91	17.72	14.23	12.44
Return on Equity (ROE)	-65.37%	-61.55%	-54.09%	-41.00%	-48.13%	-40.35%
Return on Assets (ROA)	-55.73%	-50.27%	-50.24%	-42.69%	-44.49%	-37.75%
Return on Invested Capital (ROIC)	-561.99%	-1120.35%	61060.20%	3251.43%	-7014.06%	-1537.19%
Return on Capital Employed (ROCE)	-59.44%	-54.62%	-53.90%	-45.45%	-47.90%	-39.95%
Earnings Yield	-156.29%	-199.18%	-26.35%	-15.19%	-15.21%	-20.07%
FCF Yield	-136.41%	-171.69%	-19.88%	-10.81%	-10.19%	-15.89%
Buyback Yield / Dilution	-1.17%	-1.37%	-3.10%	-39.75%	-17.21%	-67.94%
Total Shareholder Return	-1.17%	-1.37%	-3.10%	-39.75%	-17.21%	-67.94%

Updated May 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q